Horacio D. Rozanski - 11 May 2026 Form 4 Insider Report for MARRIOTT INTERNATIONAL INC /MD/ (MAR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 May 2026, 17:18:36 UTC
Prior SEC filing
02 Apr 2026
Next SEC filing
21 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Andrew P.C. Wright, Attorney-in-Fact

Key filing fact

Horacio D. Rozanski filed Form 4 for MARRIOTT INTERNATIONAL INC /MD/ (MAR) on 13 May 2026.

Key facts

  • This page summarizes Horacio D. Rozanski's Form 4 filing for MARRIOTT INTERNATIONAL INC /MD/ (MAR).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 May 2026, 17:18.

Change

  • Previous filing in this sequence was filed on 02 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001505495 Primary reporting owner

ROZANSKI HORACIO

Relationship
Director
Address
7750 WISCONSIN AVENUE, BETHESDA
Signature
Andrew P.C. Wright, Attorney-in-Fact
Signature date
13 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MAR transaction

Class A Common Stock-Dir. Def. Stock Comp Plan-1

Award

Transaction value
Shares
+670
Change %
+13%
Price
$0.000000*
Shares after
5,853
Date
11 May 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MAR transaction Derivative

Stock Appreciation Rights

Award

Transaction value
Shares
+663
Change %
Price
$0.000000*
Shares after
663
Date
11 May 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
663
Exercise price
$350.84
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

Footnote F2

Board retainer fee received in the form of SARs. The SARs are fully vested and will be exercisable on the last business day immediately preceding the next annual meeting of stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .